Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Villiger

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Therapeutische Umschau. Revue Therapeutique|November 14, 2002
[Inflammatory and degenerative joint diseases]Peter M Villiger
The Journal of Allergy and Clinical Immunology|November 2, 2013
Reply: To PMID 23154083Peter M Villiger
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Systemic sclerosis]Peter M Villiger
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Proteins in rheumatology and clinical immunology]Peter M Villiger
The Journal of Rheumatology|June 2, 2021
Giant Cell Arteritis: Real-life ExperiencePeter M Villiger
Transplant Immunology|August 16, 2002
Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritisMonika Ostensen, Peter M Villiger
Springer Seminars in Immunopathology|June 2, 2006
Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseasesBurkhard Möller, Peter M Villiger
Arthritis and Rheumatism|March 13, 2003
Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et alMichael Seitz, Peter M Villiger
Expert Review of Clinical Immunology|May 13, 2016
Treatment of rheumatoid arthritis during pregnancy: present and futureFrauke Förger, Peter M Villiger
Nature Reviews. Rheumatology|February 19, 2020
Publisher Correction: Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activityFrauke Förger, Peter M Villiger
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Therapeutische Umschau. Revue Therapeutique|November 14, 2002
[Inflammatory and degenerative joint diseases]Peter M Villiger
The Journal of Allergy and Clinical Immunology|November 2, 2013
Reply: To PMID 23154083Peter M Villiger
Therapeutische Umschau. Revue Therapeutique|July 16, 2008
[Systemic sclerosis]Peter M Villiger
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Proteins in rheumatology and clinical immunology]Peter M Villiger
The Journal of Rheumatology|June 2, 2021
Giant Cell Arteritis: Real-life ExperiencePeter M Villiger
Transplant Immunology|August 16, 2002
Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritisMonika Ostensen, Peter M Villiger
Springer Seminars in Immunopathology|June 2, 2006
Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseasesBurkhard Möller, Peter M Villiger
Arthritis and Rheumatism|March 13, 2003
Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et alMichael Seitz, Peter M Villiger
Expert Review of Clinical Immunology|May 13, 2016
Treatment of rheumatoid arthritis during pregnancy: present and futureFrauke Förger, Peter M Villiger
Nature Reviews. Rheumatology|February 19, 2020
Publisher Correction: Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activityFrauke Förger, Peter M Villiger
Pageof 14